The Indian Supreme Court's landmark decision to uphold India's Patents Act in the face of the seven-year challenge by Swiss pharmaceutical company Novartis is a major victory for patients' access to affordable medicines in developing countries.
Here, MSF's Leena Menghaney responds outside the Supreme Court after the verdict was read on 1 April.
For more information, visit: msfaccess.org/about-us/media-room/press-releases/indian-supreme-court-delivers-verdict-novartis-case
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?